ロード中...
Randomized Phase II Trial Designs With Biomarkers
Efficient development of targeted therapies that may only benefit a fraction of patients requires clinical trial designs that use biomarkers to identify sensitive subpopulations. Various randomized phase III trial designs have been proposed for definitive evaluation of new targeted treatments and th...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Clinical Oncology
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3434989/ https://ncbi.nlm.nih.gov/pubmed/22869885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.43.3946 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|